Delivery Order SPE2DB22D2206-SPE2DB25FJH30
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,796.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $9,798.71. This competitive, non-set-aside award is structured as a firm fixed price delivery order with an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,130.81 on July 31, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, competitively awarded contract has an ultimate completion date of August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $14,267.84 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) valued at $10,494.63. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $8,178.05 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) under a firm fixed price contract. The award was made on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $3,364.00 to AmerisourceBergen Drug Corp for Jardiance 10 mg tablets (90-count packages) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, consistent...
- The Defense Logistics Agency awarded a delivery order valued at $10,908.03 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets in a 90-count package. This firm fixed-price delivery order, issued on July 28, 2025, is expected to be completed by July 29, 2025. The award represents a non-competitive set-aside contract executed through AmerisourceBergen's existing indefinite delivery vehicle with DLA Troop Support Medical. The product will be delivered to the contractor's...
- The Defense Logistics Agency awarded a $7,108.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 25 mg, a diabetes medication. The contract was competitively awarded without set-aside designation and has an ultimate completion date of August 11, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply delivery. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,988.71 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg, a diabetes medication. This non-competitive, firm fixed-price delivery order was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025. The contractor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award represents a routine pharmaceutical supply delivery under...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJH30Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 10 mg, a diabetes medication, under a firm fixed-price contract valued at $15,333.22. The award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, was made without set-aside designation through competitive procedures. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance for this delivery order, which is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order represents a routine pharmaceutical supply transaction under AmerisourceBergen's existing IDC vehicle with DLA, valued at $999,999,999.00 through December 2026. AmerisourceBergen operates as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains a substantial portfolio of federal contracts covering a broad range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. This specific award for Jardiance exemplifies the company's role in supporting Defense Health Agency operations and broader military healthcare supply requirements through DLA's pharmaceutical procurement programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.3k | 8/8/25 |